Among 1994 ED patients with untreated opioid use disorder, 7-day extended-release injectable buprenorphine did not improve day-7 treatment engagement vs sublingual buprenorphine (40.5% vs 38.5%; adjusted difference 1.6%, 95% CI -2.8% to 6.0%). Precipitated withdrawal was rare.
RCTn = 2,000
D'Onofrio et al. Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial